Pharmaceutical Technology on MSN
Jazz and Roche’s Zepzelca-Tecentriq wins FDA ES-SCLC approval
A combination therapy of Jazz Pharmaceutical’s Zepzelca (lurbinectedin) and Roche’s Tecentriq (atezolizumab) has gained US ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback